Global Cleanroom Technology Market Trends
Growing demand for maintaining a contamination-free environment during sample collection and testing for possible COVID-19 cases has helped the industry despite the current epidemic. Pharma and biopharmaceutical firms have made significant investments in the market as a result of increased COVID-19 vaccine research and development efforts, which aim to prevent environmental contamination. Furthermore, the anticipated expiration of many branded drugs' 20-year patents in the upcoming years is expected to drive significant investments in the development of generic drugs and increase demand for these products, including consumables and equipment, to eliminate contamination during production procedures.
Furthermore, the need to maintain an antimicrobial environment by reducing the level of airborne particles in these facilities develops as the number of hospitals and ambulatory surgery centers (ASCs) increases due to the variety of services they offer. The government's initiatives to increase mask manufacture during the COVID-19 pandemic have contributed to the cleanroom technology market's growth. For instance, in cooperation with the French government, KOLMI-HOPEN (a division of Medicom Group) started manufacturing masks in April 2020 in a 14,300 square-meter production facility featuring an ISO 8 cleanroom spanning more than 1,000 square meters. Cleanroom technology is expected to be driven by increased demand for these consumables and equipment, especially protective masks, as a result of the global COVID-19 pandemic.